This white paper will discuss the importance of risk-based monitoring and CAPA in clinical research within the context of the following initiatives by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA):2013 GuidanceClin...
The post How to Use Risk-Based Monitoring and Clinical CAPA to Ensure Compliance appeared first on Knowledge Hub Media.